![Robert Case](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Robert Case is currently the President at FasTraq, Inc. He previously worked as the Chief Executive Officer at Quantech Ltd.
Robert Case active positions
Companies | Position | Start |
---|---|---|
FasTraq, Inc.
![]() FasTraq, Inc. Medical SpecialtiesHealth Technology FasTraq, Inc. provides blood diagnosis solutions. The company's product includes FasTraQ ER-CPC workstation. It was founded in 2002 and is headquartered in Henderson, NV. | President | - |
Former positions of Robert Case
Companies | Position | End |
---|---|---|
Quantech Ltd.
![]() Quantech Ltd. Medical SpecialtiesHealth Technology Quantech Ltd. engages in system design to increases the productivity, speed and cost effectiveness of the hospital emergency department through 'FasTraQ' a patient treatment information platform. The FasTraQ consists of an instrument that sits on the top of a counter and reads PrePaQ disposable test cartridges developed by the company. Its technology creates surface plasmon resonance in a controlled environment which enables the FasTraQ to detect and transmit information concerning the presence and quantity of certain native and foreign molecules in blood, urine which associated with specific diseases | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
FasTraq, Inc.
![]() FasTraq, Inc. Medical SpecialtiesHealth Technology FasTraq, Inc. provides blood diagnosis solutions. The company's product includes FasTraQ ER-CPC workstation. It was founded in 2002 and is headquartered in Henderson, NV. | Health Technology |
Quantech Ltd.
![]() Quantech Ltd. Medical SpecialtiesHealth Technology Quantech Ltd. engages in system design to increases the productivity, speed and cost effectiveness of the hospital emergency department through 'FasTraQ' a patient treatment information platform. The FasTraQ consists of an instrument that sits on the top of a counter and reads PrePaQ disposable test cartridges developed by the company. Its technology creates surface plasmon resonance in a controlled environment which enables the FasTraQ to detect and transmit information concerning the presence and quantity of certain native and foreign molecules in blood, urine which associated with specific diseases | Health Technology |
- Stock Market
- Insiders
- Robert Case